Lee, D K C <br/><br/>
Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma.  [electronic resource] 

 -  The European respiratory journal  Aug 2004 
 - 226-30 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0903-1936 
<br/><br/><label>Standard No.: </label>10.1183/09031936.04.00100303  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetates--administration & dosage<br/>Administration, Inhalation<br/>Adult<br/>Aspirin--adverse effects<br/>Asthma--chemically induced<br/>Confidence Intervals<br/>Cross-Over Studies<br/>Cyclopropanes<br/>Cysteine--drug effects<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Leukotrienes--metabolism<br/>Lysine--adverse effects<br/>Male<br/>Middle Aged<br/>Nasal Provocation Tests<br/>Peak Expiratory Flow Rate<br/>Quinolines--administration & dosage<br/>Reference Values<br/>Reproducibility of Results<br/>Spirometry<br/>Sulfides